Interest in Genetic Testing in Ashkenazi Jewish Parkinson's Disease Patients and Their Unaffected Relatives
Open Access
- 17 August 2014
- journal article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 24 (2) , 238-246
Abstract
Our objective was to explore interest in genetic testing among Ashkenazi Jewish (AJ) Parkinson's Disease (PD) cases and first‐degree relatives, as genetic testing for LRRK2 G2019S is widely available. Approximately 18 % of AJ PD cases carry G2019S mutations; penetrance estimations vary between 24 and 100 % by age 80. A Genetic Attitude Questionnaire (GAQ) was administered at two New York sites to PD families unaware of LRRK2 G2019S mutation status. The association of G2019S, age, education, gender and family history of PD with desire for genetic testing (outcome) was modeled using logistic regression. One‐hundred eleven PD cases and 77 relatives completed the GAQ. Both PD cases and relatives had excellent PD‐specific genetic knowledge. Among PD, 32.6 % “definitely” and 41.1 % “probably” wanted testing, if offered “now.” Among relatives, 23.6 % “definitely” and 36.1 % “probably” wanted testing “now.” Desire for testing in relatives increased incrementally based on hypothetical risk of PD. The most important reasons for testing in probands and relatives were: if it influenced medication response, identifying no mutation, and early prevention and treatment. In logistic regression, older age was associated with less desire for testing in probands OR = 0.921 95%CI 0.868–0.977, p = 0.009. Both probands and relatives express interest in genetic testing, despite no link to current treatment or prevention.Keywords
This publication has 16 references indexed in Scilit:
- A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonismNeurobiology of Aging, 2014
- Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutationsMovement Disorders, 2013
- Knowledge of and Interest in Genetic Results Among Parkinson Disease Patients and CaregiversJournal of Genetic Counseling, 2013
- Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's diseaseJournal of the Neurological Sciences, 2011
- Kin‐cohort analysis of LRRK2‐G2019S penetrance in Parkinson's diseaseMovement Disorders, 2011
- Genetic Testing and Parkinson Disease: Assessment of Patient Knowledge, Attitudes, and InterestJournal of Genetic Counseling, 2011
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- Fear of health insurance loss among individuals at risk for Huntington diseaseAmerican Journal of Medical Genetics Part A, 2008
- Interest in predictive testing for Parkinson's disease: Impact of neuroprotective therapyParkinsonism & Related Disorders, 2007
- The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson diseaseNeurology, 2007